“A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding protein”. J. Biol. Chem.277 (43): 40362–7. (October 2002). doi:10.1074/jbc.M206194200. PMID12171929.
“Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation”. Genes Dev.7 (8): 1572–83. (August 1993). doi:10.1101/gad.7.8.1572. PMID8101826.
“DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci”. Nat. Genet.25 (3): 269–77. (July 2000). doi:10.1038/77023. PMID10888872.
“Phosphorylation of human Fen1 by cyclin-dependent kinase modulates its role in replication fork regulation”. Oncogene22 (28): 4301–13. (July 2003). doi:10.1038/sj.onc.1206606. PMID12853968.
“Regulation of human flap endonuclease-1 activity by acetylation through the transcriptional coactivator p300”. Mol. Cell7 (6): 1221–31. (June 2001). doi:10.1016/s1097-2765(01)00272-6. PMID11430825.
“The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA-binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21”. J. Biol. Chem.272 (39): 24522–9. (September 1997). doi:10.1074/jbc.272.39.24522. PMID9305916.
“Interaction of human AP endonuclease 1 with flap endonuclease 1 and proliferating cell nuclear antigen involved in long-patch base excision repair”. Biochemistry40 (42): 12639–44. (October 2001). doi:10.1021/bi011117i. PMID11601988.
“p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues”. Oncogene20 (4): 484–9. (January 2001). doi:10.1038/sj.onc.1204113. PMID11313979.
“Characterization of MyD118, Gadd45, and proliferating cell nuclear antigen (PCNA) interacting domains. PCNA impedes MyD118 AND Gadd45-mediated negative growth control”. J. Biol. Chem.275 (22): 16810–9. (June 2000). doi:10.1074/jbc.275.22.16810. PMID10828065.
“Identification of a functional domain in a GADD45-mediated G2/M checkpoint”. J. Biol. Chem.275 (47): 36892–8. (November 2000). doi:10.1074/jbc.M005319200. PMID10973963.
“Interaction of CR6 (GADD45gamma ) with proliferating cell nuclear antigen impedes negative growth control”. J. Biol. Chem.276 (4): 2766–74. (January 2001). doi:10.1074/jbc.M005626200. PMID11022036.
“A novel oncostatin M-inducible gene OIG37 forms a gene family with MyD118 and GADD45 and negatively regulates cell growth”. J. Biol. Chem.274 (35): 24766–72. (August 1999). doi:10.1074/jbc.274.35.24766. PMID10455148.
“Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modification”. J. Biol. Chem.277 (23): 20974–8. (June 2002). doi:10.1074/jbc.M202504200. PMID11929879.
“PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition”. Oncogene19 (46): 5291–7. (November 2000). doi:10.1038/sj.onc.1203901. PMID11077446.
“UV-induced binding of ING1 to PCNA regulates the induction of apoptosis”. J. Cell Sci.114 (Pt 19): 3455–62. (October 2001). doi:10.1242/jcs.114.19.3455. PMID11682605.
“Ku antigen, an origin-specific binding protein that associates with replication proteins, is required for mammalian DNA replication”. Biochim. Biophys. Acta1578 (1–3): 59–72. (October 2002). doi:10.1016/s0167-4781(02)00497-9. PMID12393188.
“Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen”. J. Biol. Chem.275 (50): 39458–65. (December 2000). doi:10.1074/jbc.M006626200. PMID10978339.
“Functional interaction of proliferating cell nuclear antigen with MSH2-MSH6 and MSH2-MSH3 complexes”. J. Biol. Chem.275 (47): 36498–501. (November 2000). doi:10.1074/jbc.C000513200. PMID11005803.
“Human homolog of the MutY repair protein (hMYH) physically interacts with proteins involved in long patch DNA base excision repair”. J. Biol. Chem.276 (8): 5547–55. (February 2001). doi:10.1074/jbc.M008463200. PMID11092888.
“Direct interaction of proliferating cell nuclear antigen with the small subunit of DNA polymerase delta”. J. Biol. Chem.277 (27): 24340–5. (July 2002). doi:10.1074/jbc.M200065200. PMID11986310.
“Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta”. J. Biol. Chem.276 (52): 49258–66. (December 2001). doi:10.1074/jbc.M106990200. PMID11595739.
“Identification of a novel protein, PDIP38, that interacts with the p50 subunit of DNA polymerase delta and proliferating cell nuclear antigen”. J. Biol. Chem.278 (12): 10041–7. (March 2003). doi:10.1074/jbc.M208694200. PMID12522211.
“Human DNA polymerase lambda functionally and physically interacts with proliferating cell nuclear antigen in normal and translesion DNA synthesis”. J. Biol. Chem.277 (50): 48434–40. (December 2002). doi:10.1074/jbc.M206889200. PMID12368291.
“Over-expression of human DNA polymerase lambda in E. coli and characterization of the recombinant enzyme”. Genes Cells7 (7): 639–51. (July 2002). doi:10.1046/j.1365-2443.2002.00547.x. PMID12081642.
“Replication factor C interacts with the C-terminal side of proliferating cell nuclear antigen”. J. Biol. Chem.272 (3): 1769–76. (January 1997). doi:10.1074/jbc.272.3.1769. PMID8999859.
“The DNA-binding subunit p140 of replication factor C is upregulated in cycling cells and associates with G1 phase cell cycle regulatory proteins”. J. Mol. Med.77 (4): 386–92. (April 1999). doi:10.1007/s001090050365. PMID10353443.
“A complex consisting of human replication factor C p40, p37, and p36 subunits is a DNA-dependent ATPase and an intermediate in the assembly of the holoenzyme”. J. Biol. Chem.272 (30): 18974–81. (July 1997). doi:10.1074/jbc.272.30.18974. PMID9228079.
“Cloning and characterization of hCTF18, hCTF8, and hDCC1. Human homologs of a Saccharomyces cerevisiae complex involved in sister chromatid cohesion establishment”. J. Biol. Chem.278 (32): 30051–6. (August 2003). doi:10.1074/jbc.M211591200. PMID12766176.
“Characterisation of the interaction between WRN, the helicase/exonuclease defective in progeroid Werner's syndrome, and an essential replication factor, PCNA”. Mech. Ageing Dev.124 (2): 167–74. (February 2003). doi:10.1016/s0047-6374(02)00131-8. PMID12633936.
“PCNA: a silent housekeeper or a potential therapeutic target?”. Trends in Pharmacological Sciences35 (4): 178–186. (Apr 2014). doi:10.1016/j.tips.2014.02.004. PMID24655521.
“A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding protein”. J. Biol. Chem.277 (43): 40362–7. (October 2002). doi:10.1074/jbc.M206194200. PMID12171929.
“Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation”. Genes Dev.7 (8): 1572–83. (August 1993). doi:10.1101/gad.7.8.1572. PMID8101826.
“DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci”. Nat. Genet.25 (3): 269–77. (July 2000). doi:10.1038/77023. PMID10888872.
“Phosphorylation of human Fen1 by cyclin-dependent kinase modulates its role in replication fork regulation”. Oncogene22 (28): 4301–13. (July 2003). doi:10.1038/sj.onc.1206606. PMID12853968.
“Regulation of human flap endonuclease-1 activity by acetylation through the transcriptional coactivator p300”. Mol. Cell7 (6): 1221–31. (June 2001). doi:10.1016/s1097-2765(01)00272-6. PMID11430825.
“The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA-binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21”. J. Biol. Chem.272 (39): 24522–9. (September 1997). doi:10.1074/jbc.272.39.24522. PMID9305916.
“Interaction of human AP endonuclease 1 with flap endonuclease 1 and proliferating cell nuclear antigen involved in long-patch base excision repair”. Biochemistry40 (42): 12639–44. (October 2001). doi:10.1021/bi011117i. PMID11601988.
“p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues”. Oncogene20 (4): 484–9. (January 2001). doi:10.1038/sj.onc.1204113. PMID11313979.
“Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA”. Oncogene11 (10): 1931–7. (November 1995). PMID7478510.
“Characterization of MyD118, Gadd45, and proliferating cell nuclear antigen (PCNA) interacting domains. PCNA impedes MyD118 AND Gadd45-mediated negative growth control”. J. Biol. Chem.275 (22): 16810–9. (June 2000). doi:10.1074/jbc.275.22.16810. PMID10828065.
“Characterisation of the interaction between PCNA and Gadd45”. Oncogene10 (12): 2427–33. (June 1995). PMID7784094.
“Identification of a functional domain in a GADD45-mediated G2/M checkpoint”. J. Biol. Chem.275 (47): 36892–8. (November 2000). doi:10.1074/jbc.M005319200. PMID10973963.
“Interaction of CR6 (GADD45gamma ) with proliferating cell nuclear antigen impedes negative growth control”. J. Biol. Chem.276 (4): 2766–74. (January 2001). doi:10.1074/jbc.M005626200. PMID11022036.
“A novel oncostatin M-inducible gene OIG37 forms a gene family with MyD118 and GADD45 and negatively regulates cell growth”. J. Biol. Chem.274 (35): 24766–72. (August 1999). doi:10.1074/jbc.274.35.24766. PMID10455148.
“Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modification”. J. Biol. Chem.277 (23): 20974–8. (June 2002). doi:10.1074/jbc.M202504200. PMID11929879.
“PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition”. Oncogene19 (46): 5291–7. (November 2000). doi:10.1038/sj.onc.1203901. PMID11077446.
“UV-induced binding of ING1 to PCNA regulates the induction of apoptosis”. J. Cell Sci.114 (Pt 19): 3455–62. (October 2001). doi:10.1242/jcs.114.19.3455. PMID11682605.
“Ku antigen, an origin-specific binding protein that associates with replication proteins, is required for mammalian DNA replication”. Biochim. Biophys. Acta1578 (1–3): 59–72. (October 2002). doi:10.1016/s0167-4781(02)00497-9. PMID12393188.
“Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen”. J. Biol. Chem.275 (50): 39458–65. (December 2000). doi:10.1074/jbc.M006626200. PMID10978339.
“Functional interaction of proliferating cell nuclear antigen with MSH2-MSH6 and MSH2-MSH3 complexes”. J. Biol. Chem.275 (47): 36498–501. (November 2000). doi:10.1074/jbc.C000513200. PMID11005803.
“Human homolog of the MutY repair protein (hMYH) physically interacts with proteins involved in long patch DNA base excision repair”. J. Biol. Chem.276 (8): 5547–55. (February 2001). doi:10.1074/jbc.M008463200. PMID11092888.
“Direct interaction of proliferating cell nuclear antigen with the small subunit of DNA polymerase delta”. J. Biol. Chem.277 (27): 24340–5. (July 2002). doi:10.1074/jbc.M200065200. PMID11986310.
“Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta”. J. Biol. Chem.276 (52): 49258–66. (December 2001). doi:10.1074/jbc.M106990200. PMID11595739.
“Identification of a novel protein, PDIP38, that interacts with the p50 subunit of DNA polymerase delta and proliferating cell nuclear antigen”. J. Biol. Chem.278 (12): 10041–7. (March 2003). doi:10.1074/jbc.M208694200. PMID12522211.
“Human DNA polymerase lambda functionally and physically interacts with proliferating cell nuclear antigen in normal and translesion DNA synthesis”. J. Biol. Chem.277 (50): 48434–40. (December 2002). doi:10.1074/jbc.M206889200. PMID12368291.
“Over-expression of human DNA polymerase lambda in E. coli and characterization of the recombinant enzyme”. Genes Cells7 (7): 639–51. (July 2002). doi:10.1046/j.1365-2443.2002.00547.x. PMID12081642.
“Replication factor C interacts with the C-terminal side of proliferating cell nuclear antigen”. J. Biol. Chem.272 (3): 1769–76. (January 1997). doi:10.1074/jbc.272.3.1769. PMID8999859.
“The DNA-binding subunit p140 of replication factor C is upregulated in cycling cells and associates with G1 phase cell cycle regulatory proteins”. J. Mol. Med.77 (4): 386–92. (April 1999). doi:10.1007/s001090050365. PMID10353443.
“A complex consisting of human replication factor C p40, p37, and p36 subunits is a DNA-dependent ATPase and an intermediate in the assembly of the holoenzyme”. J. Biol. Chem.272 (30): 18974–81. (July 1997). doi:10.1074/jbc.272.30.18974. PMID9228079.
“Cloning and characterization of hCTF18, hCTF8, and hDCC1. Human homologs of a Saccharomyces cerevisiae complex involved in sister chromatid cohesion establishment”. J. Biol. Chem.278 (32): 30051–6. (August 2003). doi:10.1074/jbc.M211591200. PMID12766176.
“Characterisation of the interaction between WRN, the helicase/exonuclease defective in progeroid Werner's syndrome, and an essential replication factor, PCNA”. Mech. Ageing Dev.124 (2): 167–74. (February 2003). doi:10.1016/s0047-6374(02)00131-8. PMID12633936.
“Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen”. Cancer Res.59 (2): 342–6. (January 1999). PMID9927044.
“PCNA: a silent housekeeper or a potential therapeutic target?”. Trends in Pharmacological Sciences35 (4): 178–186. (Apr 2014). doi:10.1016/j.tips.2014.02.004. PMID24655521.